pregabalin
FDA Approved
Description
Pregabalin is a structural analogue of GABA that binds to voltage-gated calcium channels, reducing neurotransmitter release. It is effective for neuropathic pain management in hereditary motor neuropathies including Charcot-Marie-Tooth disease variants. The medication can significantly reduce pain intensity and improve functional outcomes in affected patients.
Indications & Therapeutic Use
neuropathic pain, diabetic peripheral neuropathy, fibromyalgia, partial seizures
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
pregabalin
| Generic Name | pregabalin |
| Brands | 1 brand available |
| Active Ingredient | pregabalin |
| Drug Class | neuropathic pain |
| Manufacturer | Pfizer |
| Dosage Forms | oral capsule 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg; oral solution 20mg/mL |
| Medical Code | N03AX16 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes